Health

Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products

CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and…

7 months ago

BlueWillow Biologics Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications

ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of…

7 months ago

arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology

Schlieren, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Round co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher…

7 months ago

CJ Biomaterials signs partnership with BIQ Materials to produce artificial turf infill made with PHACT PHA, a certified biodegradable biopolymer, for the European market

CJ Biomaterials signed an agreement with BIQ Materials, a Swedish biomaterials compounding company, to accelerate the commercialization of PHACT™ PHA-based…

7 months ago

Outset Medical to Present at the 2025 Stifel Healthcare Conference

November 05, 2025 09:00 ET  | Source: Outset Medical, Inc. SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset…

7 months ago

Solana Company (NASDAQ: HSDT) Releases Investor Update

November 05, 2025 09:00 ET  | Source: Solana Company NEWTOWN, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:…

7 months ago

Fueling Discovery: Misophonia Research Fund Launches New Team Science Award, Expands 2026 Funding Opportunities, and Announces Latest Grantee Cohort

CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, announces a…

7 months ago

Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025

New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its…

7 months ago

Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek

CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company…

7 months ago